Evidence map›Paper›PMID 41849042›Full record

ReviewCardiovascular drugs and therapy2026

MicroRNAs and Long Non-coding RNAs Associated With Sirtuin Pathways in Myocardial Ischemia/Reperfusion Injury.

Anna Nowak-Szwed, Ceren Eyileten, Zofia Wicik, Sara Ahmadova, Dirk von Lewinski, Harald Sourij, Marek Postula

Abstract readReview
In one paragraph

Review in Cardiovascular drugs and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna Nowak-SzwedDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology (CePT), Warsaw, Poland.ORCID http://orcid.org/0000-0001-9158-1055
Ceren EyiletenDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology (CePT), Warsaw, Poland. ceyileten@wum.edu.pl.ORCID http://orcid.org/0000-0002-3324-9625
Zofia WicikDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology (CePT), Warsaw, Poland.ORCID http://orcid.org/0000-0002-2857-1986
Sara AhmadovaDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology (CePT), Warsaw, Poland.ORCID http://orcid.org/0000-0002-7060-6775
Dirk von LewinskiDepartment of Internal Medicine, Division of Cardiology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-9996-6128
Harald SourijDivision of Endocrinology and Diabetology, Cardiometabolic Trials Unit, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-3510-9594
Marek PostulaDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology (CePT), Warsaw, Poland.ORCID http://orcid.org/0000-0002-7826-4458

Funding

Austrian Science Fund (FWF) KLIF-1155-BAustrian Science Fund (FWF) PIN8074224Horizon Europe project PoCCardio 101095432NAWA STER programme BPI/STE/2024/1/00027/U/00001NAWA/Walczak programme BPN/WAL/2024/1/00057Polish Medical Research Agency (ABM) 2019/ABM/01/00037Polish National Science Center (NCN) 2022/45/N/NZ7/0246
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ischemia/reperfusion injurylncRNAmicroRNAmiRNAMyocardial infarctionncRNASirtuin

Identifiers

PMID41849042
PMCPMC13578044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.